Understanding how UTX affects gene regulation in cancer and development
Role of UTX condensation in chromatin regulation
This study is looking at how a protein called UTX helps control gene activity in cancer cells and stem cells, which could lead to new insights for patients dealing with cancer and developmental disorders caused by UTX mutations.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10993110 on NIH RePORTER |
What this research studies
This research investigates the role of UTX, a crucial tumor suppressor, in regulating gene expression through its unique properties in chromatin. The study focuses on how UTX interacts with other proteins to form dynamic structures that influence cancer cell behavior and stem cell differentiation. By examining these interactions and the biophysical characteristics of UTX, the research aims to uncover new insights into its function in various cancers and developmental disorders. Patients may benefit from a deeper understanding of how UTX mutations contribute to their conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with cancers or neurodevelopmental disorders linked to UTX mutations, such as Kabuki syndrome.
Not a fit: Patients without UTX mutations or those with unrelated conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for cancers and developmental disorders associated with UTX mutations.
How similar studies have performed: Other research has shown promising results in understanding the role of chromatin regulation in cancer, suggesting that this approach could yield valuable insights.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Jiang, Hao — University of Virginia
- Study coordinator: Jiang, Hao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.